企業概要
Doximity, Inc. is a digital platform provider that serves the medical professional community within the United States, offering specialized tools designed to facilitate collaboration among colleagues, disseminate current medical news and research, and assist in the management of patient care operations. This enterprise operates within the Healthcare sector, specifically categorized under Health Information Services, where it leverages technology to digitize and streamline essential workflows for healthcare practitioners. The company demonstrates a substantial market presence with a market capitalization of $3.98B and generates an annual revenue of $637.78M, supported by a workforce of 830 employees. These financial figures indicate that Doximity has established itself as a significant player in the health information services landscape, commanding a valuation that reflects strong market confidence in its recurring revenue model and its critical role in the daily operations of the medical community.
財務健全性
Doximity reports a trailing twelve-month revenue of $637.78M, which resulted in a net income of $239.40M and an EBITDA of $245.46M, illustrating a highly efficient cost structure where the gap between revenue and net income is minimal due to the high-margin nature of its software licensing and subscription services. The company generated free cash flow of $213.63M, a metric that signifies robust financial flexibility allowing the firm to fund operations, invest in product development, or pursue strategic opportunities without relying on external capital markets. The company maintains exceptional profitability across all levels, boasting a gross margin of 89.7%, an operating margin of 38.9%, and a profit margin of 37.5%, which collectively indicate that the business model incurs very low incremental costs relative to each additional dollar of sales. On the balance sheet, Doximity holds $735.13M in cash against a negligible debt level of $10.69M, resulting in a debt-to-equity ratio of 1.09, although the overwhelming cash position effectively neutralizes any leverage concerns. Liquidity is further reinforced by a current ratio of 6.63, suggesting the company possesses more than six times the current assets necessary to cover its short-term liabilities, thereby ensuring an extremely secure short-term financial position. Furthermore, the return on equity stands at 23.8% while the return on assets is 12.8%, metrics that reveal management is highly effective at deploying capital to generate returns that significantly exceed the cost of equity and debt.
バリュエーション評価
The stock carries a trailing twelve-month P/E ratio of 17.78 compared to a forward P/E of 13.02, implying that the market expects earnings growth that will eventually bridge this gap and bring the valuation multiple closer to the forward estimate over the coming fiscal periods. The price-to-book ratio is recorded at 4.00, indicating that the market values the company's equity at four times its book value, a premium that typically reflects the intangible value of its proprietary platform, network effects, and recurring revenue streams which are not fully captured on the balance sheet. Alternative valuation metrics such as a price-to-sales ratio of 6.25 and an EV/EBITDA of 12.97 suggest that investors are willing to pay a premium for revenue growth and high cash generation capabilities typical of the SaaS business model. Regarding price volatility, the stock has a 52-week high of $76.51 and a 52-week low of $20.55, meaning the current trading price sits significantly below the recent peak, reflecting the recent earnings contraction mentioned in growth metrics. The beta of 1.42 indicates that the stock price is historically more volatile than the broader market, moving approximately 42% more than the benchmark index during periods of market fluctuation.
Growth & Income
Revenue growth for the trailing twelve months stands at 9.8%, while earnings growth is reported at -16.2%, indicating that earnings are currently growing at a slower rate than revenue, a divergence that often occurs during periods of increased investment in sales or infrastructure, or when one-time costs impact the bottom line. As a non-dividend payer, Doximity has a dividend yield of N/A and a payout ratio of 0.0%, which signifies that the company does not distribute profits to shareholders but instead retains earnings to fuel internal expansion, research, and development initiatives. This approach aligns with the growth profile of a company in the health information services sector that prioritizes reinvestment over income generation for investors seeking current yield. Overall, the company presents a growth-oriented profile characterized by high margins and strong cash flow, though the recent decline in earnings growth warrants observation to determine if operational efficiencies can be restored to match the revenue expansion trajectory.